AdvaMed "small" firms already get user fee "credit":
This article was originally published in Clinica
In reaction to the proposal to introduce a user fee tax credit in the state of Massachusetts (see Clinica 1107), Stephen Ubl, AdvaMed's executive vice-president for federal government relations, called the plan "interesting", but added that the current user fee programme already gives small companies a break by charging them lower user fees. The law defines small companies as those firms with annual sales of under $30m; this rather liberal definition makes it possible for most of industry to qualify. He asked rhetorically how many "truly small companies" there are that enjoy sales amounting into $30m a year.
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.